Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5500 participants
OBSERVATIONAL
2011-04-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
NCT02787213
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth
NCT06664554
Protein and Ultrasound Indicators of Preterm Birth
NCT01412931
Prediction and Prevention of Preterm Birth (PREVENT-PTB Study)
NCT03530332
Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
NCT00700219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with preterm delivery
No interventions assigned to this group
Women without preterm delivery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has a singleton pregnancy.
* Subject is able to provide consent.
Exclusion Criteria
* There is a known or suspected fetal anomaly.
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sera Prognostics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Durlin E Hickok, MD, MPH
Role: STUDY_DIRECTOR
Sera Prognostics, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maricopa Integrated Health System
Phoenix, Arizona, United States
San Diego Perinatal Clinic
San Diego, California, United States
Christiana Care Health System
Newark, Delaware, United States
Baystate Medical Center
Springfield, Massachusetts, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Ohio State University
Columbus, Ohio, United States
Oregon Health and Science University
Portland, Oregon, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Regional Obstetrical Consultants
Chattanooga, Tennessee, United States
University of Texas Medical Branch at Galveston
Galveston, Texas, United States
Intermountain Medical Center Suite 100, 5121 S. Cottonwood Street ,
Murray, Utah, United States
McKay-Dee Hospital Center
Ogden, Utah, United States
LDS Hospital
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Esplin MS, Merrell K, Goldenberg R, Lai Y, Iams JD, Mercer B, Spong CY, Miodovnik M, Simhan HN, van Dorsten P, Dombrowski M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2011 May;204(5):391.e1-8. doi: 10.1016/j.ajog.2010.09.021. Epub 2010 Nov 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sera - 004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.